Absence of pharmacokinetic interaction between ofloxacin and fenbufen in rats
- 1 October 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 41 (10) , 717-719
- https://doi.org/10.1111/j.2042-7158.1989.tb06349.x
Abstract
The possible pharmacokinetic interaction between a new quinolone and fenbufen was investigated by comparing the plasma concentration-time profiles and serum protein binding of ofloxacin, fenbufen and its active metabolite, felbinac, in rats. The rats were administered intravenous doses of ofloxacin (5 mg kg−1), fenbufen (10 mg kg−1) alone or concomitantly. The plasma elimination half-lives were about 55 min in both groups. A slight elevation of plasma concentration of ofloxacin and a small decrease of its total body clearance were observed after its coadministration with fenbufen. The extent of ofloxacin binding to rat serum tended to be slightly reduced by fenbufen which coexisted at relatively high concentrations. Plasma concentration-time curves, pharmacokinetic parameters and serum protein binding of fenbufen and felbinac were not affected by the coadministration with ofloxacin. These results suggest that any substantive pharmacokinetic interaction may be unlikely after the concomitant administration of ofloxacin and fenbufen.This publication has 12 references indexed in Scilit:
- Effect of the anti-inflammatory agent fenbufen on the quinolone-induced inhibition of γ-aminobutyric acid binding to rat brain membranes in vitroBiochemical Pharmacology, 1988
- Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranesAntimicrobial Agents and Chemotherapy, 1988
- Clinical Pharmacokinetics of the Newer Antibacterial 4-QuinolonesClinical Pharmacokinetics, 1988
- Simultaneous determination of ofloxacin, fenbufen and felbinac in rat plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- A case with convulsion, loss of consciousness and subsequent acute renal failure caused by enoxacin and fenbufen.Nihon Naika Gakkai Zasshi, 1988
- Entry of the new quinolone antibacterial agents of ofloxacin and NY-198 into the central nervous system in rats.Journal of Pharmacobio-Dynamics, 1988
- Study of the cerebrospinal fluid penetrability of ofloxacinInfection, 1986
- Fluorinated quinolonesInternational Journal of Clinical Pharmacy, 1986
- Administration of heparin causes release of non-esterified fatty acids in human plasmaLife Sciences, 1980
- INFLUENCE OF FREE FATTY ACID CONCENTRATION ON DRUG BINDING TO PLASMA ALBUMIN*Annals of the New York Academy of Sciences, 1973